24-Well Chemotaxis / Cell Invasion Assay Combo Kits

  • Fully quantify chemotaxis and cell invasion with no manual cell counting
  • Includes two plates with 8 µm membrane inserts: one uncoated for chemotaxis and one precoated on top of the membrane with ECM matrix (basement membrane) for cell invasion
  • Colorimetric or fluorometric quantitation

 

Frequently Asked Questions about Chemotaxis Assays

Frequently Asked Questions about Cell Invasion Assays

Email To BuyerPrint this PageCopy Link
Ordering

Please contact your distributor for pricing.

CytoSelect™ 24-Well Cell Migration and Invasion Assay Combo Kit, 8 µm
Catalog Number
CBA-100-C
Size
12 migration assays + 12 invasion assays
Detection
Colorimetric
Manual/Data Sheet Download
SDS Download
Price
$795.00
CytoSelect™ 24-Well Cell Migration and Invasion Assay Combo Kit, 8 µm
Catalog Number
CBA-101-C
Size
12 migration assays + 12 invasion assays
Detection
Fluorometric
Manual/Data Sheet Download
SDS Download
Price
$795.00
CytoSelect™ 24-Well Cell Migration and Invasion Assay Combo Kit, 8 µm
Catalog Number
CBA-100-C-5
Size
5x12 migration assays + 5x12 invasion assays
Detection
Colorimetric
Manual/Data Sheet Download
SDS Download
Price
$3,385.00
Product Details

If you are assaying both invasive and migratory properties of your cells, order one of our economic CytoSelect™ Cell Migration  / Invasion Assay Combo kits. These kits save you money compared to buying separate chemotaxis and cell invasion kits.

Each 24-well combo kit provides sufficient reagents to perform 12 cell migration plus 12 cell invasion assays.

Migration of Human Fibrosarcoma HT-1080 Cells.Cells were seeded at 30,000 cells per well of a 24-well plate and allowed to migrate toward 10% FBS for 4 hours in either the presence or absence of 2µM Cytochalasin D. Migratory cells on the bottom of the polycarbonate membrane were stained (top) or quantified in a fluorescence plate reader (bottom).

Effects of Cytochalasin D on Invading Cells using the CytoSelect™ 24-Well Cell Invasion Assay. HT-1080 and NIH3T3 cells (negative control) were seeded at 300,000 cells/well and allowed to invade toward 10% FBS for 24 hrs in the presence or absence of 2µM Cytochalasin D. Invasive cells, on the bottom of the invasion membrane, were stained (above) and then quantified at OD 560 nm after extraction using a standard plate reader (not shown).

Recent Product Citations
  1. Quinn, S. et al. (2016). Adenylyl cyclase 3/adenylyl cyclase-associated protein 1 (CAP1) complex mediates the anti-migratory effect of forskolin in pancreatic cancer cells. Mol. Carcinog. doi:10.1002/mc.22598 (#CBA-100-C).
  2. Komina, A. et al. (2016). Antiprolierative and pro-apoptotic effects of miR-4286 inhibition in melanoma cells. PLoS One 11:e0168229 (#CBA-100-C).
  3. Nahar, S. et al. (2016). Systematic evaluation of biophysical and functional characteristics of selenomethylene locked nucleic acid mediated inhibition of miR-21. Biochemistry doi:10.1021/acs.biochem.6b00895 (#CBA-100-C).
  4. Airoldi, I. et al. (2016). Interleukin-30 promotes breast cancer growth and progression. Cancer Res. 76:6218-6229 (#CBA-100-C).
  5. Li, X. S. & He, X. L. (2016). Kallikrein 12 downregulation reduces AGS gastric cancer cell proliferation and migration. Genet Mol Res. doi:10.4238/gmr.15038452 (#CBA-100-C).
  6. Li, Y. et al. (2016). p27 is a candidate prognostic biomarker and metastatic promoter in osteosarcoma. Cancer Res. doi:10.1158/0008-5472.CAN-15-3189 (#CBA-100-C).
  7. Du, L. et al. (2016). Transcriptome profiling reveals novel gene expression signatures and regulating transcription factors of TGFβ-induced epithelial-to-mesenchymal transition. Cancer Med. doi:10.1002/cam4.719 (#CBA-100-C).
  8. Costa, H. et al. (2016). Human cytomegalovirus may promote tumour progression by upregulating arginase-2. Oncotarget. doi:10.18632/oncotarget.9722 (#CBA-100-C).
  9. Fu, X. et al. (2016). Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer. Onco Targets Ther. 9:221120 (#CBA-100-C).
  10. Yoo, B. et al. (2015). Combining miR-10b–targeted nanotherapy with low-dose doxorubicin elicits durable regressions of metastatic breast cancer. Cancer Res. 75:4407-4415 (#CBA-100-C).
  11. Bose, D. et al. (2015). Selective inhibition of miR-21 by phage display screened peptide. Nucleic Acids Res. doi: 10.1093/nar/gkv185 (#CBA-100-C).
  12. Cai, X. Z. et al. (2015). iTRAQ-based quantitative proteomic analysis of nasopharyngeal carcinoma. J Cell Biochem.  doi: 10.1002/jcb.25105 (#CBA-100-C).
  13. Zheng, X. et al. (2015). Targeting LunX inhibits non-small-cell lung cancer growth and metastasis. Cancer Res.  doi: 10.1158/0008-5472 (#CBA-100-C).
  14. Kim, K. S. et al. (2015). Increased expression of endocan in arthritic synovial tissues: Effects of adiponectin on the expression of endocan in fibroblast-like synoviocytes. Mol Med Rep. 11:2695-2702 (#CBA-100-C).
  15. Liu, Y. et al. (2014). The role of von Willebrand factor as a biomarker of tumor development in hepatitis B virus-associated human hepatocellular carcinoma: A quantitative proteomic based study. J Proteomics. 106:99-112 (#CBA-100-C).
  16. Chavali, P. L. et al. (2014). TLX activates MMP-2, promotes self-renewal of tumor spheres in neuroblastoma and correlates with poor patient survival. Cell Death Dis. 5:e1502 (#CBA-100-C).
  17. Barui, S. et al. (2014). Simultaneous delivery of doxorubicin and curcumin encapsulated in liposomes of pegylated RGDK-lipopeptide to tumor vasculatureBiomaterials. 35:1643-1656 (#CBA-100-C).
  18. Peng, Y. et al. (2014). microRNA-503 inhibits gastric cancer cell growth and epithelial-to-mesenchymal transition. Oncol Lett. 7:1233-1238 (#CBA-100-C).
  19. Fatemi, M. et al. (2014). Epigenetic silencing of CHD5, a novel tumor-suppressor gene, occurs in early colorectal cancer stages. Cancer. 120:172-180 (#CBA-100-C).
  20. Kawamura, M. et al. (2014). The Prognostic Significance of Eukaryotic Elongation Factor 1 Alpha-2 in Non-Small Cell Lung Cancer. Anticancer Res. 34:651-658 (#CBA-100-C).
  21. Li, M. et al. (2013). Physiological Role of the Interaction between CARMIL1 and Capping Protein. Hum. Reprod. 28:2822-2831 (#CBA-100-C).
  22. Majid, S. et al. (2013). miRNA-34b Inhibits Prostate Cancer through Demethylation, Active Chromatin Modifications, and AKT Pathways. Clin. Cancer. Res. 19: 73-84 (#CBA-100-C).
  23. Majid, S. et al. (2012). miR-23b Represses Proto-oncogene Src Kinase and Functions as Methylation-Silenced Tumor Suppressor with Diagnostic and Prognostic Significance in Prostate Cancer. Cancer Res. 72:6435-6446 (#CBA-100-C).
  24. Shin, S.Y. et al. (2012). Transcriptional Regulation of the Interleukin-11 Gene by Oncogenic Ras. Carcinogenesis. 10.1093/carcin/bgs297 (#CBA-100-C).
  25. Saini, S. et al. (2012). miRNA-708 Control of CD44+ Prostate Cancer–Initiating Cells. Cancer. Res. 72: 3618-3630 (#CBA-100-C).
  26. Dennis, M. et al. (2012). Snail Controls the Mesenchymal Phenotype and Drives Erlotinib Resistance in Oral Epithelial and Head and Neck Squamous Cell Carcinoma Cells. Otolaryngology--Head and Neck Surgery. 147: 726-732 (#CBA-100-C).
  27. Dalezis, P. et al. (2012). Dexamethasone Plus Octreotide Regimen Increases Anticancer Effects of Docetaxel on TRAMP-C1 Prostate Cancer Model. In Vivo 26:75-86 (#CBA-100-C).
  28. Kahlert, C. et al. (2011). Overexpression of ZEB2 at the Invasion Front of Colorectal Cancer is an Independent Prognastic Marker and Regulates Tumor Invasion In Vitro. Clin. Cancer Res. 17:7654-7663 (#CBA-100-C).
  29. Shin, S.Y. et al. (2010). TNFα-exposed Bone Marrow-derived Mesenchymal Stem Cells Promote Locomotion of MDA-MB-231 Breast Cancer Cells through Transcriptional Activation of CXCR3 Ligand Chemokines. J. Biol. Chem. 285: 30731-30740 (#CBA-100-C).
  30. Liu, S. et al. (2008). Matrix Metalloproteinase-Activated Anthrax Lethal Toxin Demonstrates High Potency in Targeting Tumor Vasculature. J. Biol. Chem. 283:529-540 (#CBA-100-C).
  31. Ke, X-S. et al. (2008). Epithelial to Mesenchymal Transition of a Primary Prostate Cell Line with Switches of Cell Adhesion Modules but Without Malignant Transformation. PLoS One 3(10):e3368 (#CBA-100-C).
  32. Isakova, I. et al. (2007). Age and Dose-Related Effects on MSC Engraftment Levels and Anatomical Distribution in the CNS of Non-Human Primates: Identification of Novel MSC Subpopulations that Respond to Guidance Cues in Brain. Stem Cells 25:3261-3270 (#CBA-100-C).
  33. Bhansali, M. et al. (2015). TM4SF3 and AR: A nuclear complex that stabilizes both proteins. Mol Endocrinol. doi:10.1210/me.2015-1075 (#CBA-101-C).
  34. Lombard, A. P. et al. (2015). Dicer ablation promotes a mesenchymal and invasive phenotype in bladder cancer cells. Oncol Rep. 34:1526-1532 (#CBA-101-C).
  35. Saini, S. et al. (2014). Regulation of SRC Kinases by microRNA-3607 Located in a Frequently Deleted Locus in Prostate Cancer. Mol Cancer Ther. 13:1952-1963 (#CBA-101-C).
  36. Uddin, M. et al. (2008). Marinobufagenin inhibits proliferation and migration of cytotrophoblast and CHO cells. Placenta 29(3):266-273 (#CBA-101-C). 
  37. Gobeil, S. et al. (2008). A Genome-Wide shRNA Screen Identifies GAS1 as a Novel Melanoma Metastasis Suppressor Gene. Genes Dev. 22(21):2932-2940 (#CBA-101-C).